{"id":"dextromethophan","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT02212275"],"aliases":["Delsym Cough Syrup"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"The clinical trial for Dextromethorphan, led by Duke University, has been discontinued, and as a result, its potential therapeutic indication and significance are no longer being explored. The discontinuation of this trial may be due to various reasons, including lack of efficacy or unforeseen side effects. Further research is needed to determine the full potential of this drug.","brandName":"Dextromethophan","companyId":"duke-university","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","oneSentence_ai":"Dextromethorphan acts on the brain to produce effects such as cough suppression, but its exact mechanism of action is not fully understood and is still being researched.","technicalDetail":""},"commercial":null,"references":[],"ai_enriched":true,"biosimilars":[],"companyName":"Duke University","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"}],"genericName":"Dextromethophan","indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02212275","phase":"Phase 2","title":"Initial Development of Cortical Metrics, an Objective, Physiologically-Based Outcome Measure, for Intervention Trials in Autism Spectrum Disorders (ASD)","status":"WITHDRAWN","sponsor":"Duke University","isPivotal":true,"enrollment":0,"indication":"Autism Spectrum Disorders","completionDate":"2016-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Rare Disease"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}